Page last updated: 2024-11-13

cytoskyrin a

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

cytoskyrin A: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID44566948
CHEMBL ID449103
MeSH IDM0377971

Synonyms (2)

Synonym
CHEMBL449103
cytoskyrin a
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (10)

Assay IDTitleYearJournalArticle
AID334567Antibacterial activity against Escherichia coli ATCC 25922 at 10 ug/disk by agar plate diffusion assay2002Journal of natural products, May, Volume: 65, Issue:5
New metabolites from sponge-derived fungi Curvularia lunata and Cladosporium herbarum.
AID334575Antifungal activity against Candida albicans at 10 ug/disk by agar plate diffusion assay2002Journal of natural products, May, Volume: 65, Issue:5
New metabolites from sponge-derived fungi Curvularia lunata and Cladosporium herbarum.
AID334568Antibacterial activity against Escherichia coli HBI 101 at 5 ug/disk by agar plate diffusion assay2002Journal of natural products, May, Volume: 65, Issue:5
New metabolites from sponge-derived fungi Curvularia lunata and Cladosporium herbarum.
AID334574Antifungal activity against Candida albicans at 5 ug/disk by agar plate diffusion assay2002Journal of natural products, May, Volume: 65, Issue:5
New metabolites from sponge-derived fungi Curvularia lunata and Cladosporium herbarum.
AID334566Antibacterial activity against Bacillus subtilis 168 at 10 ug/disk by agar plate diffusion assay2002Journal of natural products, May, Volume: 65, Issue:5
New metabolites from sponge-derived fungi Curvularia lunata and Cladosporium herbarum.
AID334564Antibacterial activity against Bacillus subtilis 168 at 5 ug/disk by agar plate diffusion assay2002Journal of natural products, May, Volume: 65, Issue:5
New metabolites from sponge-derived fungi Curvularia lunata and Cladosporium herbarum.
AID334563Antibacterial activity against Staphylococcus aureus ATCC 25923 at 10 ug/disk by agar plate diffusion assay2002Journal of natural products, May, Volume: 65, Issue:5
New metabolites from sponge-derived fungi Curvularia lunata and Cladosporium herbarum.
AID334562Antibacterial activity against Staphylococcus aureus ATCC 25923 at 5 ug/disk by agar plate diffusion assay2002Journal of natural products, May, Volume: 65, Issue:5
New metabolites from sponge-derived fungi Curvularia lunata and Cladosporium herbarum.
AID334565Antibacterial activity against Escherichia coli ATCC 25922 at 5 ug/disk by agar plate diffusion assay2002Journal of natural products, May, Volume: 65, Issue:5
New metabolites from sponge-derived fungi Curvularia lunata and Cladosporium herbarum.
AID334569Antibacterial activity against Escherichia coli HBI 101 at 10 ug/disk by agar plate diffusion assay2002Journal of natural products, May, Volume: 65, Issue:5
New metabolites from sponge-derived fungi Curvularia lunata and Cladosporium herbarum.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (7)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (71.43)29.6817
2010's2 (28.57)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.75

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.75 (24.57)
Research Supply Index2.08 (2.92)
Research Growth Index4.83 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.75)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other7 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]